Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
Completed
Conditions studied: Asthma
In brief
Asthma is one of the most common childhood diseases. It is chronic and often severely disabling. The amount of nitric oxide that is exhaled while breathing increases with airway inflammation, a symptom of asthma. This study will examine the results from a previous study, the Cincinnati Asthma Prevention (CAP) study, to evaluate the effects of environmental and genetic factors on exhaled nitric oxide (eNO) levels and to determine the relationship between eNO and asthma severity.
Key facts
- Study ID
- NCT00395096
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 225
- Starts
- 2006-07-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2021-08-09
Who can join
Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participated in the Cincinnati Asthma Prevention Study
- Diagnosis of asthma
- Lives with someone that smokes at least 5 cigarettes a day
You may not qualify if…
- No additional neuromuscular or respiratory disorder that may interfere with safe participation in the parent study
- Does not have electricity
- Plans to move within 1 year of entry into the parent study
Where it is running
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.